| Financing Update | |
| | |
|
EMED Mining Public Limited, the Europe-based minerals development and exploration company, provides the following update on its near and long term financing strategy.
On 24 December 2014, the Company announced that it had agreed an unsecured bridging finance facility for up to US$30 million (the "Loan") with Trafigura Beheer BV ("Trafigura"), Orion Mine Finance (Master) Fund I LP ("Orion") and Hong Kong Xiangguang International Holdings Limited ("Hong Kong Xiangguang"), an affiliate of Yanggu Xiangguang Copper Co. Limited ("XGC") (Trafigura, Orion and Hong Kong Xiangguang being the "Lenders"). Furthermore the Company announced that it had agreed with Orion and XGC that the maturity date of the secured convertible loan notes issued in July 2013 (the "Convertible Notes") shall be extended to be consistent with the date for repayment of the Loan (the "Note Extension").
For further information:
|
|
|
EMED Mining Public Ltd
|
|
DEVELOPMENT STAGE |
CODE : EMED.L |
ISIN : CY0000100319 |
|
| |
ProfileMarket IndicatorsVALUE : Projects & res.Press releasesAnnual reportRISK : Asset profileContact Cpy |
EMED is a gold and copper development stage company based in Cyprus. EMED develops gold, copper and zinc in Cyprus and in Spain, and holds various exploration projects in Cyprus. Its main assets in development are PROYECTO RIO TINTO in Spain and KLIROU in Cyprus and its main exploration properties are DETVA, STIAVNICA-HODRUSA and BIELY VRCH in Slovakia and KLIROU in Cyprus. EMED is listed in United Kingdom. Its market capitalisation is GBX 54.7 billions as of today (US$ 65.5 billions, € 57.4 billions). Its stock quote reached its lowest recent point on September 18, 2015 at GBX 0.12, and its highest recent level on January 17, 2022 at GBX 404.00. EMED has 135 475 650 shares outstanding. |